Aptus Pharma Ltd vs Ganga Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Aptus Pharma Ltd is ₹ 422.5 as of 05 May 15:30 . The P/E Ratio of Aptus Pharma Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Ganga Pharmaceuticals Ltd changed from 113.9 on March 2022 to 63.6 on March 2025 . This represents a CAGR of -13.56% over 4 years The Market Cap of Aptus Pharma Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Ganga Pharmaceuticals Ltd changed from ₹ 4.16 crore on March 2022 to ₹ 4.92 crore on March 2025 . This represents a CAGR of 4.28% over 4 years The Revenue of Aptus Pharma Ltd is ₹ 0 crore as of Jun '24 .The Revenue of Ganga Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 . The EBITDA of Aptus Pharma Ltd is ₹ 0 crore as of Jun '24 .The EBITDA of Ganga Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 . The Net Profit of Aptus Pharma Ltd is ₹ 0 crore as of Jun '24 .The Net Profit of Ganga Pharmaceuticals Ltd is ₹ 0 crore as of Jun '24 . The Dividend Payout of Aptus Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Ganga Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Aptus Pharma Ltd

Aptus Pharma Limited was originally incorporated as 'Aptus Pharma Private Limited', as a private limited company with the Registrar of Companies, Gujarat, pursuant to a Certificate of Incorporation dated August 12, 2010.
Subsequently, Company was converted into a public limited retaining the name as 'Aptus Pharma Limited' and a fresh certificate of incorporation dated December 12, 2024 was issued by the Registrar of Companies, Central Processing Centre. Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations.
While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model with 7 units. under various arrangements.
It provide a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products.

About Ganga Pharmaceuticals Ltd

Ganga Pharmaceuticals Ltd was incorporated as a Public Limited Company in Aug.'94 and promoted by Brij Mohan Sharma. he Company is engaged in the business of manufacturing & trading in Pharmaceuticals & allied products (Ayurveda). In Apr.'95, the company took over Ganga pharmaceuticals, a proprietory concern (owned by the same promoter), which was manufacturing and marketing ayurvedic products since the last two decades. The company which manufactures ayurvedic medicines, started commercial production in Apr.'95.
In Jul.'96, it came out with a public issue to part-finance the expansion programme involving setting up of a new manufacturing unit for the manufacture of ayurvedic medicines at Murbad, Maharashtra. The company which commenced exports in Jan.'96, has marketing arrangements with parties located in Saudi Arabia, Dubai, Italy, Romania and Russia to market its products in their respective regions.

FAQs for the comparison of Aptus Pharma Ltd and Ganga Pharmaceuticals Ltd

Which company has a larger market capitalization, Aptus Pharma Ltd or Ganga Pharmaceuticals Ltd?

Market cap of Aptus Pharma Ltd is 289 Cr while Market cap of Ganga Pharmaceuticals Ltd is 7 Cr

What are the key factors driving the stock performance of Aptus Pharma Ltd and Ganga Pharmaceuticals Ltd?

The stock performance of Aptus Pharma Ltd and Ganga Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aptus Pharma Ltd and Ganga Pharmaceuticals Ltd?

As of May 5, 2026, the Aptus Pharma Ltd stock price is INR ₹422.5. On the other hand, Ganga Pharmaceuticals Ltd stock price is INR ₹12.0.

How do dividend payouts of Aptus Pharma Ltd and Ganga Pharmaceuticals Ltd compare?

To compare the dividend payouts of Aptus Pharma Ltd and Ganga Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.